About Celcuity (NASDAQ:CELC)
Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patient's tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival.
Industry, Sector and Symbol:
- Industry: Bio Diagnostics & Testing
- Sub-Industry: N/A
- Sector: Bio Diagnostics & Testing
- Symbol: NASDAQ:CELC
- CUSIP: N/A
- Web: celcuity.com
- Current Ratio: 14.83%
- Quick Ratio: 14.83%
- Employees: 15
- Outstanding Shares: 10,080,000
Frequently Asked Questions for Celcuity (NASDAQ:CELC)
What is Celcuity's stock symbol?
Celcuity trades on the NASDAQ under the ticker symbol "CELC."
Who are some of Celcuity's key competitors?
Some companies that are related to Celcuity include MannKind Corporation (MNKD), Avadel Pharmaceuticals PLC. (AVDL), Mersana Therapeutics (MRSN), Superior Uniform Group (SGC), 3SBio (SSRX), Microsemi Communications (VTSS), National CineMedia (NCMI), Exa Corporation (EXA), Voyager Therapeutics (VYGR), AVEO Pharmaceuticals (AVEO), Novavax (NVAX), America First Multifamily Investors, L.P. (ATAX), The First Bancshares (FBMS), NuCana PLC Sponsored ADR (NCNA), The Finish Line (FINL), Artesian Resources Corporation (ARTNA), Gladstone Investment Corporation (GAIN) and American Software (AMSWA).
When did Celcuity IPO?
(CELC) raised $18 million in an initial public offering (IPO) on Wednesday, September 20th 2017. The company issued 2,000,000 shares at a price of $8.00-$10.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.
When did Celcuity's quiet period expire?
Celcuity's quiet period expired on Monday, October 30th. Celcuity had issued 2,400,000 shares in its initial public offering on September 20th. The total size of the offering was $22,800,000 based on an initial share price of $9.50. During Celcuity's quiet period, insiders and underwriters involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
Who owns Celcuity stock?
Celcuity's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Gagnon Securities LLC (2.31%), Royce & Associates LP (1.15%) and Essex Investment Management Co. LLC (0.15%). View Institutional Ownership Trends for Celcuity.
Who bought Celcuity stock? Who is buying Celcuity stock?
Celcuity's stock was purchased by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, Royce & Associates LP and Essex Investment Management Co. LLC. View Insider Buying and Selling for Celcuity.
How do I buy Celcuity stock?
Shares of Celcuity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Celcuity's stock price today?
One share of Celcuity stock can currently be purchased for approximately $18.25.
How big of a company is Celcuity?
Celcuity has a market capitalization of $184 million. The company earns ($3,310,000.00) in net income (profit) each year or ($0.65) on an earnings per share basis. Celcuity employs 15 workers across the globe.
How can I contact Celcuity?
Celcuity's mailing address is 16305 36th Ave N Ste 450, MINNEAPOLIS, MN 55446-4280, United States. The company can be reached via phone at +1-763-3920767.
MarketBeat Community Rating for Celcuity (NASDAQ CELC)MarketBeat's community ratings are surveys of what our community members think about Celcuity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Celcuity (NASDAQ:CELC) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Celcuity (NASDAQ:CELC)
Analysts' Ratings History for Celcuity (NASDAQ:CELC)
(Data available from 11/18/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/16/2017||Craig Hallum||Initiated Coverage||Buy||N/A|
Earnings History for Celcuity (NASDAQ:CELC)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Celcuity (NASDAQ:CELC)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Celcuity (NASDAQ:CELC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Celcuity (NASDAQ CELC)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Celcuity (NASDAQ:CELC)
Latest Headlines for Celcuity (NASDAQ CELC)
Financials are not available for this stock.
Celcuity (NASDAQ CELC) Chart for Saturday, November, 18, 2017